TITLE

DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatment

AUTHOR(S)
Laytragoon-Lewin, Nongnit; Rutqvist, Lars; Lewin, Freddi
PUB. DATE
September 2013
SOURCE
Medical Oncology;Sep2013, Vol. 30 Issue 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
89980923

 

Related Articles

  • Odczyn popromienny u chorych na raka regionu gÅ‚owy i szyi: mechanizmy i konsekwencje. ZIÓŁKOWSKAA, EWA; BIEDKA, MARTA; WINDORBSKA, WIESŁAWA // Otorynolaryngologia;12/1/2011, Vol. 10 Issue 4, p147 

    Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide and often is associated with a poor prognosis. Therapeutic decisions are usually based on clinical pathological parameters like stage of clinical progression, location of tumour and its histological...

  • When is radiation therapy in head and neck squamous cell carcinoma not indicated? Mendenhall, William; Strojan, Primož; Silver, Carl; Owen, Randall; Rinaldo, Alessandra; Shaha, Ashok; Eisbruch, Avraham; Takes, Robert; Ferlito, Alfio // European Archives of Oto-Rhino-Laryngology;Nov2014, Vol. 271 Issue 11, p2849 

    The author discusses the situation where radiation therapy (RT) can be eliminated in managing patients with mucosal head and neck squamous cell carcinoma (HNSCC). Topics discussed include the use of surgery as an effective treatment for HNSCC, the factors that influence the decision of excluding...

  • Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients. Gaykalova, Daria A.; Vatapalli, Rajita; Wei, Yingying; Tsai, Hua-Ling; Wang, Hao; Zhang, Chi; Hennessey, Patrick T.; Guo, Theresa; Tan, Marietta; Li, Ryan; Ahn, Julie; Khan, Zubair; Westra, William H.; Bishop, Justin A.; Zaboli, David; Koch, Wayne M.; Khan, Tanbir; Ochs, Michael F.; Califano, Joseph A. // PLoS ONE;11/6/2015, Vol. 10 Issue 10, p1 

    Head and Neck Squamous Cell Carcinoma (HNSCC) is the fifth most common cancer, annually affecting over half a million people worldwide. Presently, there are no accepted biomarkers for clinical detection and surveillance of HNSCC. In this work, a comprehensive genome-wide analysis of epigenetic...

  • Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). Smiraglia, D. J.; Smith, L. T.; Lang, J. C.; Rush, L. J.; Dai, Z.; Schuller, D. E.; Plass, C. // Journal of Medical Genetics;Jan2003, Vol. 40 Issue 1, p25 

    Head and neck squamous cell carcinomas (HNSCC) often metastasise to the cervical lymph nodes, it is known for HNSCC as well as other cancers that progression from normal tissue to primary tumour and finally to metastatic tumour is characterised by an accumulation of genetic mutations. DNA...

  • Preferential Activation of the Hedgehog Pathway by Epigenetic Modulations in HPV Negative HNSCC Identified with Meta-Pathway Analysis. Fertig, Elana J.; Markovic, Ana; Danilova, Ludmila V.; Gaykalova, Daria A.; Cope, Leslie; Chung, Christine H.; Ochs, Michael F.; Califano, Joseph A. // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Head and neck squamous cell carcinoma (HNSCC) is largely divided into two groups based on their etiology, human papillomavirus (HPV)-positive and –negative. Global DNA methylation changes are known to drive oncogene and tumor suppressor expression in primary HNSCC of both types. However,...

  • A tecnologia de microarray no estudo do câncer de cabeça e pescoço. Colombo, Jucimara; Rahal, Paula // Revista Brasileira de Biociencias;2010, Vol. 8 Issue 1, p64 

    The microarray technology is a tool for global analysis of gene expression that allows investigating hundreds or thousands of genes in a sample using a hybridization reaction. This technology is based on hybridization between labeled targets derived from biological samples and an array of many...

  • Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas. Chuan-En Huang; Cheng-Chia Yu; Fang-Wei Hu; Ming-Yung Chou; Lo-Lin Tsai // International Journal of Molecular Sciences;Sep2014, Vol. 15 Issue 9, p14935 

    Chemo-resistance is the major cause of high mortality in head and neck squamous cell carcinomas (HNSCC) in which HNSCC-derived cancer stem cells (CSCs) may be involved. Previously, we enriched a subpopulation of HNSCC-derived spheroid cells (SC) (HNSCC-SC) and identified Nanog as a CSCs marker....

  • Pilot research on the evaluation and detection of head and neck squamous cell carcinoma by Raman spectroscopy. Valdés, Roberto; Stefanov, Stefan; Chiussi, Stefano; López‐Alvarez, Miriam; González, Pío // Journal of Raman Spectroscopy;Jul2014, Vol. 45 Issue 7, p550 

    Head and neck cancer is a broad term that covers the heterogeneous group of cancers that arise in the upper aero and digestive tract, including oral cavity, pharynx and larynx. Over 90% of this type of cancers are developed in the squamous cell epithelium of the mucosal linings and are,...

  • Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis. Cameron, Sarina; de Long, Lilia Merida; Hazar-Rethinam, Mehlika; Topkas, Eleni; Endo-Munoz, Lilliana; Cumming, Andrew; Gannon, Orla; Guminski, Alexander; Saunders, Nicholas // Molecular Cancer;2012, Vol. 11 Issue 1, p74 

    Background: Overexpression of CEACAM6 has been reported for a number of malignancies. However, the mechanism of how CEACAM6 contributes to cancer formation and its role in head and neck squamous cell carcinoma (HNSCC) remains unclear. Therefore, we examined the role of CEACAM6 in head and neck...

  • Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Lemaire, F.; Millon, R.; Young, J.; Cromer, A.; Wasylyk, C.; Schultz, I.; Muller, D.; Marchal, P.; Zhao, C.; Melle, D.; Bracco, L.; Abecassis, J.; Wasylyk, B. // British Journal of Cancer;11/17/2003, Vol. 89 Issue 10, p1940 

    Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer in men with an incidence of about 780?000 new cases per year worldwide and a poor rate of survival. There is a need for a better understanding of HNSCC, for the development of rational targeted interventions and to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics